Fact CheckerSign in

NCT07497815Not yet recruiting

Artificial Intelligence-assisted Diagnosis in Ophthalmology

Development and Validation of an Artificial Intelligence-assisted Diagnostic System for Ophthalmic Pathologies

Source: ClinicalTrials.gov · Last updated 1 Apr 2026

Brief summary (registry, in English)

This is a retrospective, multicenter, observational study designed to develop and validate an artificial intelligence (AI) system capable of detecting and classifying major ophthalmic diseases (glaucoma, cataract, diabetic retinopathy, and other retinal pathologies) in the Costa Rican population. The study will use approximately 15,000 existing medical images from digital archives of two ophthalmic centers in Costa Rica, without active participant recruitment or capture of new images. The primary motivation is that AI systems developed in other countries (primarily Asian, European, or North American populations) do not necessarily perform with the same accuracy when applied to Latin American populations. This study seeks to establish a precedent for the importance of locally validating any medical AI technology before clinical implementation.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
15000 (estimated)
First submitted
23 Mar 2026
Start date
1 May 2026
Primary completion date
1 May 2028
Lead sponsor
Marisse Masis-Solano
NCT number
NCT07497815

What you commit to

  • Study type: Observational
  • Planned participants: 15000
  • From 1 May 2026 to the primary completion date, 1 May 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Images from eyes with recent intraocular surgery (\<3 months)

Age

  • Images in non-standard or corrupted formats that cannot be processed
    • Sex/Gender: All Minimum Age: 18 Years Maximum Age: No limit Accepts Healthy Volunteers: Yes (images of healthy eyes without pathology are included as controls)

Other

  • CLINICAL:
  • Images from eyes with severe ocular trauma distorting anatomy
  • Images from patients with rare or unique ocular pathologies not allowing generalization
  • Images post-recent laser treatment where acute changes may confuse analysis
    • TECHNICAL:
  • Severely degraded image quality (extreme blur, severe under/overexposure, major artifacts preventing interpretation)
  • Duplicate images of same eye on same date
  • Images with missing or clearly erroneous metadata

Who the study is looking for

  • Image corresponds to patient ≥18 years of age at time of capture
  • Image modality is one of: fundus photography, posterior segment OCT, anterior segment photography, automated perimetry, or video-OCT
  • Image quality sufficient for diagnostic interpretation (adequate resolution, focus, illumination, complete visualization of anatomical area of interest, no major artifacts)
  • Minimum clinical data available (age or age group, sex, and diagnosis or clinical indication)
  • Image captured during routine clinical care (not specifically for research)
  • No patient objection to use of medical data for research (when applicable per center policy)

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Centro Ocular
Coordinator of this site? Confirm its status
HerediaCosta RicaUnknown status
Asociados de Mácula y Vítreo de Costa Rica
Coordinator of this site? Confirm its status
San JoséCosta RicaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.